Market overview
The global catheter-directed thrombolysis market is worth USD 452 mn in 2026 and is forecast to reach USD 931 mn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Standard infusion catheters is the largest by device segment.
| Scope | Catheters that deliver clot-dissolving drugs directly into blocked veins and arteries: ultrasound-assisted systems, multi-sidehole infusion catheters and pharmacomechanical devices for pulmonary embolism, deep vein thrombosis and arterial occlusion. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 420 mn |
| Value 2026 | USD 452 mn |
| Value 2036 | USD 931 mn |
| CAGR 2026-2036 | 7.5% |
| Volume 2026 | 118 thousand catheters |
| Volume 2036 | 231 thousand catheters |
| Average price 2026 | USD 3,837 per catheter |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Catheter-Directed Thrombolysis market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 452 mn |
| 2027 | USD 485 mn |
| 2028 | USD 522 mn |
| 2029 | USD 561 mn |
| 2030 | USD 603 mn |
| 2031 | USD 648 mn |
| 2032 | USD 697 mn |
| 2033 | USD 749 mn |
| 2034 | USD 805 mn |
| 2035 | USD 866 mn |
| 2036 | USD 931 mn |
Catheter-Directed Thrombolysis market segmentation
By device
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Standard infusion catheters | 46.0% | 37.0% | USD 208 mn | 5.2% |
| Ultrasound-assisted systems | 38.0% | 42.5% | USD 172 mn | 8.7% |
| Pharmacomechanical devices | 16.0% | 20.5% | USD 72 mn | 10.2% |
By indication
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pulmonary embolism | 40.0% | 46.6% | USD 181 mn | 9.2% |
| Deep vein thrombosis | 38.0% | 35.1% | USD 172 mn | 6.7% |
| Peripheral arterial occlusion | 16.0% | 13.5% | USD 72 mn | 5.7% |
| Other | 6.0% | 4.8% | USD 27 mn | 5.2% |
By technique
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Ultrasound-assisted | 36.0% | 38.0% | USD 163 mn | 8.1% |
| Pharmaco-mechanical | 34.0% | 32.0% | USD 154 mn | 6.8% |
| Standard catheter | 30.0% | 30.0% | USD 135 mn | 7.5% |
By vessel
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Deep vein thrombosis | 50.0% | 46.0% | USD 226 mn | 6.6% |
| Pulmonary embolism | 32.0% | 35.0% | USD 144 mn | 8.5% |
| Arterial | 18.0% | 19.0% | USD 81 mn | 8.1% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 62.0% | 58.0% | USD 280 mn | 6.8% |
| Specialty vascular centers | 24.0% | 26.0% | USD 108 mn | 8.4% |
| Ambulatory surgery centers | 14.0% | 16.0% | USD 63 mn | 8.9% |
Top 25 countries for catheter-directed thrombolysis by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 87.0% of 2026 revenue and the 25 countries below together hold 96.0%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 235 mn | 52.0% | USD 489 mn | 7.6% |
| 2 | China | USD 27 mn | 6.0% | USD 68 mn | 9.6% |
| 3 | Germany | USD 27 mn | 6.0% | USD 51 mn | 6.6% |
| 4 | Japan | USD 23 mn | 5.0% | USD 41 mn | 6.1% |
| 5 | France | USD 18 mn | 4.0% | USD 34 mn | 6.7% |
| 6 | United Kingdom | USD 18 mn | 4.0% | USD 36 mn | 7.2% |
| 7 | Italy | USD 14 mn | 3.0% | USD 24 mn | 6.0% |
| 8 | Canada | USD 14 mn | 3.0% | USD 27 mn | 7.1% |
| 9 | Spain | USD 9.0 mn | 2.0% | USD 17 mn | 6.4% |
| 10 | Australia | USD 9.0 mn | 2.0% | USD 19 mn | 7.5% |
| 11 | South Korea | USD 5.9 mn | 1.3% | USD 13 mn | 8.4% |
| 12 | Netherlands | USD 5.9 mn | 1.3% | USD 12 mn | 7.2% |
| 13 | Brazil | USD 4.7 mn | 1.0% | USD 10 mn | 8.3% |
| 14 | India | USD 4.2 mn | 0.9% | USD 9.6 mn | 8.5% |
| 15 | Switzerland | USD 3.9 mn | 0.9% | USD 7.8 mn | 7.2% |
| 16 | Belgium | USD 2.8 mn | 0.6% | USD 5.7 mn | 7.2% |
| 17 | Sweden | USD 2.2 mn | 0.5% | USD 4.5 mn | 7.3% |
| 18 | Austria | USD 2.2 mn | 0.5% | USD 4.4 mn | 7.0% |
| 19 | Mexico | USD 2.0 mn | 0.5% | USD 4.6 mn | 8.4% |
| 20 | Poland | USD 1.7 mn | 0.4% | USD 3.9 mn | 8.6% |
| 21 | Taiwan | USD 1.5 mn | 0.3% | USD 3.3 mn | 8.1% |
| 22 | Israel | USD 1.1 mn | 0.2% | USD 2.1 mn | 7.0% |
| 23 | Denmark | USD 0.86 mn | 0.2% | USD 1.7 mn | 6.9% |
| 24 | Saudi Arabia | USD 0.86 mn | 0.2% | USD 1.9 mn | 8.1% |
| 25 | Singapore | USD 0.68 mn | 0.1% | USD 1.5 mn | 8.2% |
| Rest of world | USD 18 mn | 4.0% | USD 38 mn | 7.6% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Boston Scientific
- Cook Medical
- Merit Medical
Group 2: Regional and specialist players
- AngioDynamics
- Argon Medical
- Penumbra
- Medtronic
Group 3: Emerging and niche players
- Thrombolex
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the catheter-directed thrombolysis market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.5% is calculated from the resulting values.
The market is divided by device, by indication, by technique, by vessel, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the catheter-directed thrombolysis market?
The global catheter-directed thrombolysis market is estimated at USD 420 mn in 2025 and USD 452 mn in 2026.
How fast will the catheter-directed thrombolysis market grow?
It is forecast to reach USD 931 mn by 2036, a compound annual growth rate of 7.5% from 2026, an increase of USD 479 mn.
Which country is the largest market for catheter-directed thrombolysis?
United States is the largest market by revenue at USD 235 mn in 2026, 52.0% of the global total. The three largest countries together hold 64.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 9.6% a year from 2026 to 2036.
Which catheter-directed thrombolysis segment is largest?
In the by device split, Standard infusion catheters is the largest segment with 46.0% of 2026 revenue.
Who are the leading catheter-directed thrombolysis companies?
Global leaders include Boston Scientific, Cook Medical, Merit Medical.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Organ Preservation SolutionUSD 454 mn · 7.5% CAGR
- Tattoo Removal LaserUSD 454 mn · 7.5% CAGR
- Cosmetic Peptide ManufacturingUSD 456 mn · 8.0% CAGR
- PET Imaging WorkflowUSD 456 mn · 8.0% CAGR
- Home Infusion Smart Pump AccessoriesUSD 445 mn · 6.5% CAGR
- Cell-Free DNA Testing TransplantUSD 462 mn · 10.0% CAGR
- AI enhanced Mammography ScreeningUSD 434 mn · 19.0% CAGR
- Waterless Bathing SolutionUSD 475 mn · 5.3% CAGR
← Catheter-Based Pulmonary Embolism Thrombectomy Cell Culture →